Drug Discovery for Schizophrenia

This book PDF is perfect for those who love Medical genre, written by Tatiana V. Lipina and published by Royal Society of Chemistry which was released on 13 May 2015 with total hardcover pages 304. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related Drug Discovery for Schizophrenia books below.

Drug Discovery for Schizophrenia
Author : Tatiana V. Lipina
File Size : 44,9 Mb
Publisher : Royal Society of Chemistry
Language : English
Release Date : 13 May 2015
ISBN : 9781782620266
Pages : 304 pages
Get Book

Drug Discovery for Schizophrenia by Tatiana V. Lipina Book PDF Summary

Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in the field of schizophrenia with an aim to advance the understanding of scientists and clinicians in this area and to fuel drug discovery. The book outlines a change in the way schizophrenia is treated by moving away from focusing only on treating symptoms in patients. Innovative drugs emerge from deeper comprehension of the pathological processes that emerge earlier in life, hence, providing strategies for preventative therapy to alter the course of this mental disorder. Amongst other current topics, the book covers new findings in genetics and epigenetics, progress in animal models for schizophrenia and the usage of induced pluripotent stem cells. The combination of these important areas benefit psychiatric neuroscience, filling the gaps in the knowledge of neurobiology of schizophrenia and providing novel perspectives for future drug development.

Drug Discovery for Schizophrenia

Since the pioneering pharmacotherapy for treatment of schizophrenia in the 1950s by antipsychotics, only a few major innovations have been made, pointing to a general stagnation in the field of pharmacology of schizophrenia. Drug Discovery for Schizophrenia covers new insights in the field of schizophrenia with an aim to advance

Get Book
Targets and Emerging Therapies for Schizophrenia

New and emerging directions in pharmaceutical research to better treat schizophrenia Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and

Get Book
Drug Discovery for Psychiatric Disorders

This is a wide scope and in-depth coverage of the state of the art and future directions in drug discovery for major psychiatric disorders.

Get Book
Small Molecule Therapeutics for Schizophrenia

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro

Get Book
Schizophrenia

Download or read online Schizophrenia written by Lori Dirks, published by Unknown which was released on 1996-11-01. Get Schizophrenia Books now! Available in PDF, ePub and Kindle.

Get Book
First Episode Psychosis

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective

Get Book
Improving and Accelerating Therapeutic Development for Nervous System Disorders

Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling

Get Book
Antipsychotic Trials in Schizophrenia

Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the

Get Book